Refine by region/country
Latest articles in Health Care
Flash Report / Bangladesh

Unilever completes 82% acquisition of Glaxow BD, gaining ownership of HFD brands

Glaxow BD to become Unilever Consumer Care after the transfer of 9.88mn shares. Horlicks is the absolute market leader in the BDT4.1bn health food drinks (HFD) industry attaining 92% market share. On the other hand, GSK group will continue to market...
IDLC Securities Auneea Haque
Auneea Haque @ IDLC Securities 29 July 2020
Equity Analysis / Pakistan

Dexamethasone proves to be breakthrough drug for Covid-19

A UK government-funded trial has immediately approved Dexamethasone, an anti-inflammatory drug (corticosteroid), to treat all hospitalised Covid-19 patients requiring oxygen, including those on ventilators. SEARL has also recently entered licensing a...
Intermarket Securities Yusra Beg
Yusra Beg @ Intermarket Securities 17 June 2020
Macro Analysis / Global

Safeguarding Africa’s Food Security in the Age of COVID-19

Food security in sub-Saharan Africa is under threat. As a result, lives are lost, malnutrition rises, health worsens, and school enrollment drops. The measures to contain and manage the COVID-19 pandemic, while critical to saving lives, risks exacerb...
International Monetary Fund
IMF Blog 4 June 2020
Macro Analysis / Global

How the Great Lockdown Saved Lives

Since the COVID-19 outbreak was first reported in Wuhan, China in late December 2019, the disease has spread to more than 200 countries and territories. On the other hand, having a strong health system and lower population density enhanced the effect...
International Monetary Fund
IMF Blog 2 June 2020
Macro Analysis / Bangladesh

Bangladesh – Economic activities resume; we prefer Telco, Consumer, Pharma & MFS

On May 31, 2020, Bangladesh will mark the end of 66-day long ‘General Holiday’ (38 days lockdowns, 20 weekends, and 8 public holidays) as the economic activities resume on a ‘limited scale’. Now, everything is expected to reopen from May 31 including...
IDLC Securities S. M. Galibur Rahman
S. M. Galibur Rahman @ IDLC Securities 31 May 2020
Equity Analysis / Global

SEARL enters exclusive license agreement with Beximco Pharma for Remdesivir

In an exchange filing today, SEARL PA has announced that it has successfully entered into a licensing and marketing agreement with Beximco Pharmaceuticals Bangladesh for Remdesivir – a US FDA approved wide-spectrum antiviral drug used to treat advanc...
Intermarket Securities Yusra Beg
Yusra Beg @ Intermarket Securities 29 May 2020